- Therapeutic treatment
- Prophylactic treatment 
- Drug targets and candidates
- Preventive Treatment

Focuses of Pharmacology in COVID-19

- American Journal of Cancer Research
- Analytical Biochemistry
- Annals of Internal Medicine
- BioRxiv (Preprint)
- BioMedicine & Pharmacotherapy
- British Pharmacological Society
- Circulation Research
- Clinical Hypertension
- Clinical Infectious Diseases
- EBioMedicine
- Elsevier
- Emerging Microbes and Infections
- European Heart Journal
- European Journal of Pharmacology
- Frontier Public Health
- Future Medicine
- High Blood Pressure & Cardiovascular Prevention
- International Journal of Biological Macromolecules
- International Journal of Biological Sciences
- International Journal of Pharmaceutical Sciences and Research
- Journal of Biomolecular Structure and Dynamics
- medRxiv (preprint)
- Pharmacological Reports
- Proceedings of the National Academy of Sciences of the United States of America 
- ScienceDirect
- SpringerLink
- The Journal of Infectious Diseases
- The New England Journal of Medicine 
- Virus Research
- Wiley Public Health Emergency Collection
- Time Magazine 
- American Journal of Physiology: Cell Physiology


References for Pharmacology in COVID-19 by journal

The use and testing of drugs and medicine to treat COVID-19

University of Michigan - Ann Arbor

The science concerned with the study of drugs and medication. It is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. 

Pharmacology

COVID-19 refers to the newly discovered infectious disease caused by a new strain of coronavirus. This new virus and disease were first discovered during the outbreak in Wuhan, China, that reportedly began in December 2019. Before this discovery of the new virus, the Wuhan Municipal Health Commission announced that patients were sick with 'viral pneumonia' from an unknown cause.

SARS-CoV-2 (COVID-19)

A substance that causes a change in an organism's physiology or psychology when consumed. Drugs are typically distinguished from food and substances that provide nutritional support.

Drug

Pharmacology in COVID-19

- Pharmacodynamics
- Pharmacokinetics 
- Therapeutic treatment
- Prophylactic treatment 

Focuses of Pharmacology

References for pharmacology by journal

An interdisciplinary science that draws from concepts in fields such as organic chemistry, pharmacology, and biology. It focuses on the design and development of drugs. 

Medicinal Chemistry

Focuses on the influence of genetic factors on medication efficacy and tolerability

Pharmacogenetics

1. [MODULE 1: From Bench to Bedside, Section: 'GRAPHIC SUMMARY' (as of March 19, 2020)](https://docs.google.com/document/d/1gjUuqTLi7xqMVzgWeYAFulmaIiKzhYY89PVOJJVvlNo/edit#heading=h.gtn0tdsnrc43)
2. [MEDICAL STUDENT COVID-19 CURRICULUM](https://docs.google.com/document/d/13JfRRw1GEIKz4JCde8WcQBCHnu-7nn11P_z0dHov1eA/preview)


COVID-19 Graphical Summary

An unprecedented amount of knowledge has been generated in the past two months in the form of journal papers, blog posts, and other forms.
Journal reviewers have significantly expedited the review process, e.g., the New England Journal of Medicine posted a COVID-19 paper within 48 hours of submission. Many researchers disseminate their papers in the form of preprints or posts on the new Wu-han Clan Slack channel before journal publication.

Multidisciplinary Collaborative COVID-19 Research

Biomedical engineering tools, problems and solutions related to COVID-19

Biomedical engineering for COVID-19

The virology of COVID-19: How viruses infect host cells in the body

Virology of COVID-19

Health authorities in China contacted the World Health Organization (WHO) that there was a cluster of viral pneumonia cases of unknown cause in Wuhan, Hubei. By January 30th, the WHO declared the outbreak a Public Health Emergency of International Concern (PHEIC). At the time there were 7,818 cases confirmed globally, affecting 19 countries in five WHO regions.

Epidemiology of COVID-19

- Time-consuming to self-judge many rapidly released papers
- Difficult to efficiently inform the research community about inappropriate results/findings
- Repetition and contradiction
- Cognitive overload and determining the novelty of a new study
- Published papers are static and don't get updated dynamically
- Difficult for multidisciplinary research collaboration 
- The increased role of preprint servers in COVID-19 research
- Marketing and subscription fees of journals
- Personal ambitions and carrier incentives
- Even the papers published journals are not completely flawless when the time is the essence.
- Difficulty informing the public


Current Barriers Related to COVID-19 Collaborative Research

How human functions and mechanisms play a role in transmitting and fighting against COVID-19

Human physiology of COVID-19

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). The outbreak was first identified in Wuhan, China, in December 2019. The World Health Organization declared the pandemic on March 11th

COVID-19 pandemic

- Focuses of Effects of Human Nutrition in Fighting COVID-19
- References for Effects of Human Nutrition in Fighting COVID-19 by Journal/Source

Effects of Human Nutrition in Fighting COVID-19

"Long Covid", or "Long-Haul Covid", is a term that describes the experience of SARS-CoV-2 infected patients with long-term and persistent symptomology.

Learn Before

Related

Learn After